Legacy Private Trust’s AbbVie ABBV Stock Holding History

Legacy Private Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.34M	Buy	33,151 +1,533	+5%	+$330K	0.46%	45
2026 Q1	$6.88M	Buy	31,618 +373	+1%	+$82.7K	0.42%	50
2025 Q4	$7.14M	Buy	31,245 +178	+0.6%	+$40.5K	0.42%	50
2025 Q3	$7.19M	Buy	31,067 +824	+3%	+$168K	0.43%	51
2025 Q2	$5.61M	Buy	30,243 +5,226	+21%	+$971K	0.36%	55
2025 Q1	$5.24M	Sell	25,017 -199	-0.8%	-$38.7K	0.36%	57
2024 Q4	$4.48M	Buy	25,216 +915	+4%	+$168K	0.29%	68
2024 Q3	$4.8M	Buy	24,301 +3,770	+18%	+$704K	0.32%	71
2024 Q2	$3.52M	Buy	20,531 +200	+1%	+$33.1K	0.25%	79
2024 Q1	$3.7M	Sell	20,331 -614	-3%	-$106K	0.27%	81
2023 Q4	$3.25M	Sell	20,945 -115	-0.5%	-$16.8K	0.26%	83
2023 Q3	$3.14M	Sell	21,060 -723	-3%	-$106K	0.27%	79
2023 Q2	$2.93M	Buy	21,783 +335	+2%	+$49.1K	0.24%	89
2023 Q1	$3.42M	Sell	21,448 -589	-3%	-$90K	0.29%	85
2022 Q4	$3.56M	Buy	22,037 +11	+0%	+$1.69K	0.32%	80
2022 Q3	$2.96M	Sell	22,026 -964	-4%	-$138K	0.28%	86
2022 Q2	$3.52M	Sell	22,990 -477	-2%	-$72.9K	0.32%	80
2022 Q1	$3.8M	Buy	23,467 +10	+0%	+$1.45K	0.3%	81
2021 Q4	$3.18M	Sell	23,457 -135	-0.6%	-$15.9K	0.24%	90
2021 Q3	$2.54M	Sell	23,592 -368	-2%	-$42K	0.21%	93
2021 Q2	$2.7M	Sell	23,960 -5,110	-18%	-$576K	0.23%	89
2021 Q1	$3.15M	Sell	29,070 -4,440	-13%	-$475K	0.28%	86
2020 Q4	$3.59M	Sell	33,510 -3,053	-8%	-$293K	0.34%	74
2020 Q3	$3.2M	Sell	36,563 -1,500	-4%	-$141K	0.33%	76
2020 Q2	$3.74M	Buy	38,063 +3,513	+10%	+$309K	0.41%	69
2020 Q1	$2.63M	Sell	34,550 -1,075	-3%	-$91.6K	0.34%	76
2019 Q4	$3.15M	Sell	35,625 -3,000	-8%	-$249K	0.33%	79
2019 Q3	$2.92M	Sell	38,625 -10,623	-22%	-$728K	0.33%	78
2019 Q2	$3.58M	Sell	49,248 -2,211	-4%	-$174K	0.41%	66
2019 Q1	$4.15M	Buy	51,459 +8,140	+19%	+$666K	0.49%	61
2018 Q4	$3.99M	Buy	43,319 +1,478	+4%	+$130K	0.52%	56
2018 Q3	$3.96M	Buy	41,841 +9,169	+28%	+$870K	0.45%	57
2018 Q2	$3.03M	Buy	32,672 +1,355	+4%	+$132K	0.36%	69
2018 Q1	$2.96M	Sell	31,317 -2,145	-6%	-$236K	0.35%	71
2017 Q4	$3.24M	Sell	33,462 -440	-1%	-$41.5K	0.38%	70
2017 Q3	$3.01M	Buy	33,902 +7,480	+28%	+$569K	0.37%	70
2017 Q2	$1.92M	Sell	26,422 -4,300	-14%	-$289K	0.24%	91
2017 Q1	$2M	Sell	30,722 -1,482	-5%	-$93.2K	0.26%	95
2016 Q4	$2.02M	Sell	32,204 -4,125	-11%	-$252K	0.27%	97
2016 Q3	$2.29M	Buy	36,329 +1,570	+5%	+$102K	0.31%	86
2016 Q2	$2.15M	Sell	34,759 -3,579	-9%	-$218K	0.31%	91
2016 Q1	$2.19M	Buy	38,338 +1,183	+3%	+$65.9K	0.33%	83
2015 Q4	$2.2M	Sell	37,155 -1,225	-3%	-$70.6K	0.33%	81
2015 Q3	$2.09M	Sell	38,380 -83	-0.2%	-$5.4K	0.33%	86
2015 Q2	$2.58M	Sell	38,463 -5,550	-13%	-$362K	0.39%	75
2015 Q1	$2.58M	Buy	44,013 +353	+0.8%	+$21.3K	0.38%	78
2014 Q4	$2.86M	Buy	43,660 +1,090	+3%	+$68.7K	0.42%	66
2014 Q3	$2.46M	Buy	42,570 +2,100	+5%	+$117K	0.38%	79
2014 Q2	$2.29M	Buy	40,470 +6,958	+21%	+$365K	0.35%	80
2014 Q1	$1.72M	Sell	33,512 -568	-2%	-$28.7K	0.3%	86
2013 Q4	$1.8M	Buy	34,080 +500	+1%	+$24.6K	0.33%	77
2013 Q3	$1.5M	Buy	33,580 +10,245	+44%	+$454K	0.32%	74
2013 Q2	$965K	Buy	+23,335	New	+$1.02M	0.23%	90

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Legacy Private Trust's ABBV Position: Q2 2026 in Review

Legacy Private Trust increased its AbbVie (ABBV) stake by 4.8% in Q2 2026, buying an estimated $330K and bringing the position to 33,151 shares worth $8.34M. The position accounts for 0.46% of the portfolio, ranked #45.

Legacy Private Trust first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Legacy Private Trust held 33,151 shares of AbbVie worth $8.34M as of Q2 2026.
Legacy Private Trust bought 1,533 AbbVie shares in Q2 2026, an estimated $330K.
AbbVie made up 0.46% of Legacy Private Trust's portfolio in Q2 2026, its #45 holding.
Legacy Private Trust first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Legacy Private Trust's 13F filing for Q2 2026, filed 21 Jul 2026.